246 related articles for article (PubMed ID: 34641935)
1. Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective.
Hamed A; An Haack K; Gwaltney C; Baranowski E; Stewart A; Krupnick R; Tyler M; Sparks S; Paty J
Orphanet J Rare Dis; 2021 Oct; 16(1):428. PubMed ID: 34641935
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom.
Hubig L; Sussex AK; MacCulloch A; Hughes D; Graham R; Morris L; Raza S; Lloyd AJ; Sowinski A; Gallop K
J Health Econ Outcomes Res; 2023; 10(1):41-50. PubMed ID: 36883056
[No Abstract] [Full Text] [Related]
3. Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.
Wenninger S; Greckl E; Babačić H; Stahl K; Schoser B
J Neurol; 2019 Jan; 266(1):133-147. PubMed ID: 30430231
[TBL] [Abstract][Full Text] [Related]
4. Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis.
Flythe JE; Karlsson N; Sundgren A; Cordero P; Grandinetti A; Cremisi H; Rydén A
BMC Nephrol; 2021 Jun; 22(1):233. PubMed ID: 34162354
[TBL] [Abstract][Full Text] [Related]
5. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
[TBL] [Abstract][Full Text] [Related]
6. Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician Interviews.
Holmstrom S; Naidoo S; Turnbull J; Hawryluk E; Paty J; Morlock R
Patient; 2019 Feb; 12(1):57-67. PubMed ID: 30519830
[TBL] [Abstract][Full Text] [Related]
7. Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease.
Hamed A; DasMahapatra P; Lyn N; Gwaltney C; Hopkin RJ
Orphanet J Rare Dis; 2021 Jun; 16(1):285. PubMed ID: 34172077
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study.
Jackson K; Parthan A; Lauher-Charest M; Broderick L; Law N; Barnett C
Neurol Ther; 2023 Feb; 12(1):107-128. PubMed ID: 36322146
[TBL] [Abstract][Full Text] [Related]
9. Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures.
Vanherpe P; Fieuws S; D'Hondt A; Bleyenheuft C; Demaerel P; De Bleecker J; Van den Bergh P; Baets J; Remiche G; Verhoeven K; Delstanche S; Toussaint M; Buyse B; Van Damme P; Depuydt CE; Claeys KG
Orphanet J Rare Dis; 2020 Apr; 15(1):83. PubMed ID: 32248831
[TBL] [Abstract][Full Text] [Related]
10. Thematic analysis to explore patients' experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives.
Rofail D; Somersan-Karakaya S; Choi JY; Przydzial K; Zhao Y; Hussein M; Norton TD; Podolanczuk AJ; Mylonakis E; Geba GP
BMJ Open; 2024 Jan; 14(1):e076992. PubMed ID: 38233059
[TBL] [Abstract][Full Text] [Related]
11. Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature.
Hobson-Webb LD; Proia AD; Thurberg BL; Banugaria S; Prater SN; Kishnani PS
Mol Genet Metab; 2012 Aug; 106(4):462-9. PubMed ID: 22664150
[TBL] [Abstract][Full Text] [Related]
12. Toward deconstructing the phenotype of late-onset Pompe disease.
Schüller A; Wenninger S; Strigl-Pill N; Schoser B
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):80-8. PubMed ID: 22253010
[TBL] [Abstract][Full Text] [Related]
13. The Patient Experience with Diabetic Retinopathy: Qualitative Analysis of Patients with Proliferative Diabetic Retinopathy.
Sherman SA; Rofail D; Levine A; Hartford CR; Baldasaro J; Marquis P; Rao R; Do DV
Ophthalmol Ther; 2023 Feb; 12(1):431-446. PubMed ID: 36460939
[TBL] [Abstract][Full Text] [Related]
14. Development of a Conceptual Model of Physical Functioning Limitations Experienced by Patients with Late-Stage Chronic Kidney Disease: A Qualitative Interview Study.
Palmer E; Johar I; Little DJ; Karlsson N
Adv Ther; 2024 Jul; 41(7):2757-2775. PubMed ID: 38722538
[TBL] [Abstract][Full Text] [Related]
15. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
[TBL] [Abstract][Full Text] [Related]
16. Urodynamic and clinical studies in patients with late-onset Pompe disease and lower urinary tract symptoms.
Kuchenbecker KS; Kirschner-Hermanns R; Kornblum C; Jaekel A; Anding R; Kohler A
Neurourol Urodyn; 2020 Jun; 39(5):1437-1446. PubMed ID: 32343026
[TBL] [Abstract][Full Text] [Related]
17. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.
Rydén A; Nolan S; Maher J; Meyers O; Kündig A; Bjursell M
BMC Nephrol; 2022 Jun; 23(1):201. PubMed ID: 35641914
[TBL] [Abstract][Full Text] [Related]
18. The emerging phenotype of late-onset Pompe disease: A systematic literature review.
Chan J; Desai AK; Kazi ZB; Corey K; Austin S; Hobson-Webb LD; Case LE; Jones HN; Kishnani PS
Mol Genet Metab; 2017 Mar; 120(3):163-172. PubMed ID: 28185884
[TBL] [Abstract][Full Text] [Related]
19. Selective screening of late-onset Pompe disease (LOPD) in patients with non-diagnostic muscle biopsies.
Meznaric M; Fumic K; Leonardis L
J Clin Pathol; 2019 Jul; 72(7):468-472. PubMed ID: 30878973
[TBL] [Abstract][Full Text] [Related]
20. The impact of antibodies in late-onset Pompe disease: a case series and literature review.
Patel TT; Banugaria SG; Case LE; Wenninger S; Schoser B; Kishnani PS
Mol Genet Metab; 2012 Jul; 106(3):301-9. PubMed ID: 22613277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
